Effectiveness of the BNT162b2 (Pfizer-BioNTech) Vaccine in Children and Adolescents: A Systematic Review and Meta-Analysis

Efforts to control the COVID-19 pandemic have expanded to the vaccination of children and adolescents. This systematic review assesses the utility of the BNT162b2 (Pfizer-BioNTech) vaccine in children and adolescents aged 5–18 years, considering its effectiveness against COVID infection, hospital an...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabu, Jewel Maria, Zahid, Izza, Jacob, Namitha, Alele, Faith O., Malau-Aduli, Bunmi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698079/
https://www.ncbi.nlm.nih.gov/pubmed/36366387
http://dx.doi.org/10.3390/vaccines10111880

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9698079/
https://www.ncbi.nlm.nih.gov/pubmed/36366387
http://dx.doi.org/10.3390/vaccines10111880

Ejemplares similares